|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Interest income, net | |||
| Other expense | |||
| Net loss | |||
| Net loss per share, basic and diluted | |||
| Weighted-average shares outstanding, basic and diluted | |||
| Unrealized gain (loss) on short-term investments | |||
| Comprehensive loss | |||
| Net loss per share, basic | |||
| Net loss per share, Diluted | |||
| Weighted-average shares outstanding, basic | |||
| Weighted-average shares outstanding, diluted |
Loading...
